ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RSKD vs AHG // FORWARD P/E MULTIPLE

Riskified Ltd. (Class A) (NYSE) VS. Akso Health Group ADS (NASDAQ) • 15-METRIC TALLY: RSKD 8 — AHG 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RSKD VS. AHG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RSKD AHG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 51.70% -0.10% +51.80 RSKD /gross-margins <GO>
Return on Invested Capital (ROIC) -20.30% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 2.71% -1.12% +3.83 RSKD /fcf-yield <GO>
Operating Margin -9.90% -60.00% +50.10 RSKD /operating-margins <GO>
Net Profit Margin -8.00% -60.00% +52.00 RSKD /net-margins <GO>
Revenue Growth (YoY) 5.20% -6.40% +11.60 RSKD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.12 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 2/9 +5.00 RSKD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.6 53.8 +1.81 RSKD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.22B $1.14B $82.9M RSKD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RSKD REV AHG REV RSKD GROSS % AHG GROSS % RSKD FCF AHG FCF
FY 2025 $344.6M $13.8M 51.7% -0.1% $33.1M -$12.8M
FY 2024 $327.5M $14.8M 52.2% -1.9% $39.1M $1.0M
FY 2023 $297.6M $2.4M — — $7.3M $1.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RSKD // BETA —
AHG // BETA —